
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| NIVF | -99.92% | N/A | N/A | -100% |
| S&P | +12.66% | +85.37% | +13.13% | +54% |
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.
No news articles found for NewGenIvf Group.
| Q4 2024 | YOY Change | |
|---|---|---|
| Revenue | $1.27M | 0.0% |
| Gross Profit | $0.36M | 0.0% |
| Gross Margin | 28.22% | 0.0% |
| Market Cap | $46.11M | -84.4% |
| Market Cap / Employee | $0.61M | 0.0% |
| Employees | 76 | 0.0% |
| Net Income | -$0.06M | 94.1% |
| EBITDA | -$0.91M | 28.2% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2024 | YOY Change | |
|---|---|---|
| Net Cash | $0.46M | 984.1% |
| Accounts Receivable | $0.05M | 0.0% |
| Inventory | 0.1 | 0.0% |
| Q4 2024 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.34M | 0.0% |
| Short Term Debt | $0.69M | -57.5% |
| Q4 2023 | YOY Change | |
|---|---|---|
| Return On Assets | -1.50% | 0.0% |
| Return On Invested Capital | -1.85% | -2.6% |
| Q4 2024 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$6.36M | -4354.3% |
| Operating Free Cash Flow | -$6.35M | -4352.5% |
| Metric | Q4 2023 | Q3 2024 | Q4 2024 | YoY Change |
|---|---|---|---|---|
| Price to Book | 8.46 | -7.50 | -54.59 | - |
| Price to Tangible Book Value | 8464.50 | 811.17 | -3119.88 | - |
| Enterprise Value to EBITDA | -33.33 | 64.22 | -12.50 | - |
| Return on Equity | -1.6% | - | ||
| Total Debt | $1.62M | $5.27M | $3.03M | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.